Opal Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Opal Wealth Advisors's REGN Position: Q3 2026 in Review
Opal Wealth Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 1.5% in Q3 2026, selling an estimated $3.78K and leaving 335 shares worth $254K. The position accounts for 0.05% of the portfolio, ranked #172.
Opal Wealth Advisors first reported a position in REGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $327K in Q2 2024. 1,409 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Opal Wealth Advisors held 335 shares of Regeneron Pharmaceuticals worth $254K as of Q3 2026.
- Opal Wealth Advisors sold 5 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $3.78K.
- Regeneron Pharmaceuticals made up 0.05% of Opal Wealth Advisors's portfolio in Q3 2026, its #172 holding.
- Opal Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
- Opal Wealth Advisors's Regeneron Pharmaceuticals position peaked at $327K in Q2 2024.
- 1,409 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Opal Wealth Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.